Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 58 for alzheimer

Edit search filters
  1. The Cognitive Effects of Lorazepam in Healthy Older Individuals with TOMM40 Variable-length Polymorphisms

    Scottsdale/Phoenix, AZ

  2. Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

    Jacksonville, FL, Rochester, MN

  3. 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

    Rochester, MN

  4. Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects

    Scottsdale/Phoenix, AZ

  5. A Safety, Methodological and Exploratory Biomarkers Study to Slow Disease Progression

    Jacksonville, FL

  6. Bridging Study of C11 PiB and F18 Flutemetamol Brain PET

    Rochester, MN

  7. A Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer’s Disease

    Jacksonville, FL

  8. A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease

    Jacksonville, FL

  9. DaTSCAN Imaging in Aging and Neurodegenerative Disease

    Rochester, MN, Jacksonville, FL

  10. Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder

    Jacksonville, FL

.

Mayo Clinic Footer